Opiant Pharmaceuticals OPNT
$ 20.65
0.0%
Quarterly report 2022-Q3
added 11-14-2022
Opiant Pharmaceuticals EV/EBITDA Ratio 2011-2024 | OPNT
Annual EV/EBITDA Ratio Opiant Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
19.3 | -10.1 | 1.79 | -1.05 | 7.81 | -1.63 | -1.84 | 0.0148 | 0.111 | -1.99 | -0.0322 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
19.3 | -10.1 | 1.13 |